secwatch.observer — SEC 8-K summary
======================================

Issuer:     22nd Century Group, Inc. (XXII)
CIK:        0001347858
Form:       8-K
Filed at:   2022-11-08T23:59:59+00:00
Accession:  0001558370-22-016725
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

22nd Century Q3 revenue up 148% to $19.4M; net loss $13.1M, VLN expansion to 12-18 states
--------------------------------------------------------------------------------

- Net revenue $19.4M (+148% YoY); tobacco $11.5M (+47.7%), hemp/cannabis $7.8M (new).
- Operating loss widened to $15.3M from $7.6M; net loss $13.1M ($0.06/share).
- VLN cigarette launch expands to CO, AZ, NM, UT; targeting 12-18 states within 12 months.
- Full quarter of GVB Biopharma revenue included; GVB passed NSF audit, pursuing pharma-grade certifications.
- Cash and investments $43.7M; manufacturing capacity +25%; largest VLN tobacco crop planted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347858/000155837022016725/0001558370-22-016725-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347858/000155837022016725/xxii-20221108x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-016725

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer